Activation and inhibition of G proteins by lipoamines

Molecular Pharmacology

Volumn 61, Issue 3, 2002, Pages 628-636

  Breitweg Lehmann, Evelyn ^a   Czupalla, Cornelia ^a   Storm, Rüdiger ^a   Kudlacek, Oliver ^b   Schunack, Walter ^a   Freissmuth, Michael ^b   Nürnberg, Bernd ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ALKYL GROUP; AMIDE; AMINE; AMINO ACID; DIMER; FUB 132; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; MASTOPARAN; N DODECYL NALPHA,NEPSILON (BISLYSINYL)LYSINAMIDE; PEPTIDE; POLYAMINE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; HYDROLYSIS; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036182276     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.3.628     Document Type: Article

References (40)

1. Inhibition of receptor/G protein coupling by suramin analogues
2. Mammalian RGS proteins: Barbarians at the gate
3. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling
4. o3, an abundant G protein in brain
5. 187 result in loss of GTPase activity
6. iα-3
7. Suramin analogues as subtype-selective G protein inhibitors
8. G protein antagonists
9. Characterization of transducin from bovine retinal rod outer segments. I. Separation and reconstitution of the subunits
10. The many faces of G protein signaling
11. o by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity
12. 2+ and the βγ-subunit complex on the interactions of guanine nucleotides with G proteins
13. o
14. Conformational change of mastoparan from wasp venom on binding with phospholipid membrane
15. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins)
16. sα-selective G protein antagonists
17. G proteins as drug targets
18. G-protein diseases furnish a model for the turn-on switch
19. 1-adenosine receptor
20. Signal transfer from rhodopsin to the G-protein: Evidence for a two-site sequential fit mechanism
21. 15N
22. G proteins endogenously expressed in Sf9 cells: Interactions with mammalian histamine receptors
23. Alkyl-substituted amino acid amides and analogous di- and triamines: New non-peptide G protein activators
24. 125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding
25. Regulators of G-protein-mediated signaling
26. o with Purkinje cell protein-2. Evidence for a novel nucleotide exchange factor
27. G protein activation: A receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides
28. Myristoylation of G protein α-subunits
29. o-subtype from mammalian brain
30. Non-peptide G-protein activators as promising tools in cell biology and potential drug leads
31. i: Precoupling and constitutive activity
32. Regulation of G-protein activation by mastoparans and other cationic peptides
33. i proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes
34. G protein-bound conformation of mastoparan-X, a receptor mimetic peptide
35. Receptor-independent activators of heterotrimeric G-protein signaling pathways
36. α helix content of G protein α-subunit is decreased upon activation by receptor mimetics
37. Peptides as probes for G protein signal transduction
38. 2 dopamine receptors by suramin and didemethylated suramin (NF037)
39. 1-adenosine receptor and G protein α-subunits
40. Regulators of G-protein signalling: A novel protein family involved in timely deactivation and desensitization of signalling via heterotrimeric G proteins